Loading clinical trials...

F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response | Clinical Trials | Clareo Health

Back to search

TERMINATED

F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

NCT00180193•Technische Universität Dresden

View on ClinicalTrials.gov

Summary

The purpose of this study is to monitor the amino acid uptake of brain tumors, before and during radiotherapy, with positron emission tomography.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Brain tumor
•Radiation therapy indicated
•Written consent

Exclusion Criteria

•Pregnancy
•Mental impairment
•Drug/alcohol abuse

Locations (1)

Department of Nuclear Medicine

Dresden, Germany

Key Dates

Start Date

December 1, 2003

Last Updated

August 26, 2009

Enrollment

ESTIMATED participants

Conditions

Brain Tumor

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379

High Grade GliomaDiffuse Intrinsic Pontine Glioma+7 more

View study

RECRUITINGNA

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

NCT06962215

Brain Tumor Adult

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 26, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITING

PHASE1/PHASE2